BioSpace News Archive

Heska Corporation announced that Kevin Wilson, Heska’s President & Chief Executive Officer, will present at the J.P. Morgan 2019 Healthcare Conference on Thursday, January 10, 2019 at 11 a.m. PT in San Francisco, CA.

Akero Therapeutics, Inc. announced the company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA next week.

Sangamo Therapeutics, Inc. announced that Sandy Macrae, CEO of Sangamo, will present a corporate overview at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9th at 11:30 a.m. PT in San Francisco

Generation Bio announced the company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 8, 2019

The US Navy Veterans Mesothelioma Center says, “As we would like to discuss anytime at 800-714-0303 our number one passion is making certain a US Navy Veteran who has been diagnosed with mesothelioma has on the spot access to some of the nation’s most skilled and experienced mesothelioma attorneys for a better compensation settlement resul

One of the top fertility centers in the world updates name to reflect global reach

Tenax Therapeutics, Inc. (TENX), a specialty pharmaceutical company focused on identifying and developing drugs that address diseases with high unmet medical need, today announced that the Company will participate in Biotech Showcase Investor Conference in San Francisco, which takes place January 7-9, 2019

Endologix® Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today that in order to ensure optimal outcomes for patients, unrestricted sales and use of the Nellix System will cease immediately, and the product will only be available for use under clinical protocol with pre-screened patients that adhere to the current indications.

Relay Therapeutics announced that Sanjiv Patel, M.D., president and chief executive officer, is scheduled to present an overview of the company’s business and scientific objectives at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 10, 2019 at 11:00 a.m. PT (2:00 p.m. ET).

Cross-Disciplinary Syndicate Provides Growth Capital to Advance Prescription Digital Therapeutics